Citation

BibTex format

@article{Pates:2026:10.1183/23120541.00362-2026,
author = {Pates, K and Premuda, C and Frost, F and Finney, L and Nagar, J and Bhattacharyya, A and Dhar, R and Aboelhassan, A and Ru, C and Thornton, C and Tryfon, S and Papadopoulou, E and Devínek, P and Kwok, WC and Ukor, E-F and Blasi, F and Thee, S and Ekkelenkamp, M and Shah, A and Gramegna, A},
doi = {10.1183/23120541.00362-2026},
journal = {ERJ Open Research},
title = {PRESIDE protocol: a global registry of antimicrobial resistance in chronic lung disease},
url = {http://dx.doi.org/10.1183/23120541.00362-2026},
year = {2026}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Antimicrobial resistance (AMR) is an escalating global health threat. Chronic lung diseases (CLDs) represent a key area in which AMR poses unique and often underestimated challenges, yet high-quality epidemiological data remain scarce. To address this gap, the European Respiratory Society Clinical Research Collaboration on AMR in Lung Infections (AMR-Lung CRC) has developed PRESIDE, an international prospective observational registry designed to evaluate the prevalence and burden of AMR in patients with CLD. PRESIDE is a global, multicentre study recruiting paediatrics and adults with CLD who have undergone respiratory microbiological testing as part of routine clinical care within the year prior to data collection. Participating centres enroll patients during two-week recruitment periods, held twice yearly over five years from 2025 to 2030. The registry captures a comprehensive set of core variables, including demographics and smoking history, CLD type and aetiology, microbiological history, comorbidities, clinical characteristics, therapeutic exposures, and respiratory microbiology results.
AU  - Pates,K
AU  - Premuda,C
AU  - Frost,F
AU  - Finney,L
AU  - Nagar,J
AU  - Bhattacharyya,A
AU  - Dhar,R
AU  - Aboelhassan,A
AU  - Ru,C
AU  - Thornton,C
AU  - Tryfon,S
AU  - Papadopoulou,E
AU  - Devínek,P
AU  - Kwok,WC
AU  - Ukor,E-F
AU  - Blasi,F
AU  - Thee,S
AU  - Ekkelenkamp,M
AU  - Shah,A
AU  - Gramegna,A
DO  - 10.1183/23120541.00362-2026
PY  - 2026///
SN  - 2312-0541
TI  - PRESIDE protocol: a global registry of antimicrobial resistance in chronic lung disease
T2  - ERJ Open Research
UR  - http://dx.doi.org/10.1183/23120541.00362-2026
ER  -
Download